Jewett Amy, Garg Arika, Meyer Katherine, Wagner Laura Danielle, Krauskopf Katherine, Brown Kimberly A, Pan Jen-Jung, Massoud Omar, Smith Bryce D, Rein David B
Oak Ridge Institute for Science and Education, Clinton, TN, USA.
NORC at University of Chicago, Chicago, IL, USA.
Health Promot Pract. 2015 Mar;16(2):256-63. doi: 10.1177/1524839914532291. Epub 2014 Apr 28.
In 1998, the Centers for Disease Control and Prevention (CDC) published Recommendations for Prevention and Control of Hepatitis C Virus (HCV) Infection and HCV-Related Chronic Disease, recommending HCV testing for populations most likely to be infected with HCV. However, the implementation of risk-based screening has not been widely adopted in health care settings, and 45% to 85% of infected U.S. adults remain unidentified.
To develop a better understanding of why CDC's 1998 recommendations have had limited success in identifying persons with HCV infection and provide information about how CDC's 2012 Recommendations for the Identification of Chronic Hepatitis C Virus Infection Among Persons Born During 1945-1965 may be implemented more effectively.
Qualitative data were collected and analyzed from a multidisciplinary team as part of the Birth Cohort Evaluation to Advance Screening and Testing for Hepatitis C project.
Nineteen providers were asked open-ended questions to identify current perspectives, practices, facilitators, and barriers to HCV screening and testing. Providers were affiliated with Henry Ford Hospital, Mount Sinai Hospital, the University of Alabama, and the University of Texas Health Science Center.
Respondents reported the complexity of the 1998 recommendations, and numerous indicated risk factors were major barriers to effective implementation. Other hindrances to hepatitis C testing included physician discomfort in asking questions about socially undesirable behaviors and physician uncertainty about patient insurance coverage.
Implementation of the CDC's 2012 recommendations could be more successful than the 1998 recommendations due to their relative simplicity; however, effective strategies need to be used for dissemination and implementation for full success.
1998年,美国疾病控制与预防中心(CDC)发布了《丙型肝炎病毒(HCV)感染及HCV相关慢性病的预防与控制建议》,建议对最有可能感染HCV的人群进行HCV检测。然而,基于风险的筛查在医疗环境中尚未得到广泛采用,45%至85%的美国成年感染者仍未被识别。
更好地理解为何CDC 1998年的建议在识别HCV感染者方面成效有限,并提供有关如何更有效地实施CDC 2012年《关于识别1945年至1965年出生人群中的慢性丙型肝炎病毒感染的建议》的信息。
作为推进丙型肝炎筛查和检测的出生队列评估项目的一部分,从一个多学科团队收集并分析了定性数据。
向19名医疗服务提供者提出了开放式问题,以确定他们对HCV筛查和检测的当前观点、做法、促进因素和障碍。这些医疗服务提供者隶属于亨利·福特医院、西奈山医院、阿拉巴马大学和德克萨斯大学健康科学中心。
受访者报告了1998年建议的复杂性,众多指明的风险因素是有效实施的主要障碍。丙型肝炎检测的其他障碍包括医生在询问有关社会不良行为问题时感到不适,以及医生对患者保险覆盖范围的不确定性。
由于CDC 2012年的建议相对简单,其实施可能比1998年的建议更成功;然而,需要采用有效的策略进行传播和实施,才能取得全面成功。